COOLSCULPTING SYSTEM
Report
- Report Number
- 3007215625-2023-11152
- Event Type
- Injury
- Date Received
- July 28, 2023
- Date of Event
- February 15, 2019
- Report Date
- November 14, 2023
- Manufacturer
- ALLERGAN (PLEASANTON)
- Product Code
- OOK
- UDI-DI
- 00816417020001
- PMA / PMN Number
- K160259
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THIS IS A HISTORICAL RECORD AND REFLECTS REPORTS THAT WERE RECEIVED BY THE COMPANY PRIOR TO APRIL 2021. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH / PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION.
ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED WITH COOLSCULPTING TO THE MALE CHEST ON (B)(6) 2019 USING THE COOLADVANTAGE COOLCURVE+ APPLICATOR. THE PATIENT DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH) 1 MONTH AFTER TREATMENT. THE PATIENT WAS DIAGNOSED WITH PAH IN THE CHEST ON (B)(6) 2019. THE PAH WAS DESCRIBED AS FIRM AND THERE WAS VISIBLE ENLARGEMENT.
ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED WITH COOLSCULPTING TO THE MALE CHEST ON (B)(6) 2019 USING THE COOLADVANTAGE COOLCURVE+ APPLICATOR. THE PATIENT DEVELOPED PARADOXICAL HYPERPLASIA (PAH / PH) 1 MONTH AFTER TREATMENT. THE PATIENT WAS DIAGNOSED WITH PAH IN THE CHEST ON (B)(6) 2019. THE PAH WAS DESCRIBED AS FIRM AND THERE WAS VISIBLE ENLARGEMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2334039 | COOLSCULPTING SYSTEM | DERMAL COOLING PACK/VACUUM/MASSAGER | OOK | ALLERGAN (PLEASANTON) | NI | 00816417020001 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Male | Required Intervention |